Sivik Global Healthcare LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Sivik Global Healthcare LLC disclosed 33 US equity positions worth $234.6m in its Q3 2024 13F filing. The largest position was XBI at 12.6% of the reported book, followed by LLY and THC.
What did Sivik Global Healthcare LLC own in Q3 2024? Top 33 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | XBI SPDR S&P BIOTECH ETF | 12.6% | $29.6m | 300,000 | – | ||
| 2 | LLY ELI LILLY & CO | Healthcare | 5.5% | $12.8m | 14,500 | – | |
| 3 | THC TENET HEALTHCARE | Healthcare | 4.6% | $10.8m | 65,000 | – | |
| 4 | NVO NOVO-NORDISK A/S | Healthcare | 4.6% | $10.7m | 90,000 | – | |
| 5 | UHS UNIV HEALTH SVC | Healthcare | 4.4% | $10.3m | 45,000 | – | |
| 6 | MCK MCKESSON CORP | Healthcare | 4.2% | $9.9m | 20,000 | – | |
| 7 | SYK STRYKER CORP | Healthcare | 4.2% | $9.8m | 27,000 | – | |
| 8 | BSX BOSTON SCIENTIFIC CORPORATION | Healthcare | 3.8% | $8.8m | 105,000 | – | |
| 9 | ISRG INTUITIVE SURG | Healthcare | 3.7% | $8.6m | 17,500 | – | |
| 10 | DHR DANAHER CORP | Healthcare | 3.6% | $8.3m | 30,000 | – | |
| 11 | HCA HCA HEALTHCARE INC | Healthcare | 3.5% | $8.1m | 20,000 | – | |
| 12 | SGRY SURGERY PARTNERS INC | Healthcare | 3.2% | $7.4m | 230,000 | – | |
| 13 | ACHC ACADIA HEALTHCRE | Healthcare | 3.1% | $7.3m | 115,000 | – | |
| 14 | ABT ABBOTT LABS | Healthcare | 2.9% | $6.8m | 60,000 | – | |
| 15 | AVTR AVANTOR INC | Healthcare | 2.8% | $6.5m | 250,000 | – | |
| 16 | BDX BECTON DICKINSON CO | Healthcare | 2.6% | $6.0m | 25,000 | – | |
| 17 | BAX BAXTER INTERNATIONAL INC. | Healthcare | 2.4% | $5.7m | 150,000 | – | |
| 18 | COR CENCORA INC | Healthcare | 2.4% | $5.6m | 25,000 | – | |
| 19 | MDT MEDTRONIC INC | Healthcare | 2.3% | $5.4m | 60,000 | – | |
| 20 | RVTY REVVITY INC | Healthcare | 2.2% | $5.1m | 40,000 | – | |
| 21 | WST WEST PHARMACEUTICAL SERVICES INC | Healthcare | 2.2% | $5.1m | 17,000 | – | |
| 22 | CAH CARDINAL HEALTH | Healthcare | 2.1% | $5.0m | 45,000 | – | |
| 23 | SELECT MEDICAL HOLDINGS CORP | 2.1% | $4.9m | 140,000 | – | ||
| 24 | EHC ENCOMPASS HEALTH CORP | Healthcare | 2.1% | $4.8m | 50,000 | – | |
| 25 | VRTX VERTEX PHARMACEUTICALS INC. | Healthcare | 2.0% | $4.7m | 10,000 | – | |
| 26 | SNN SMITH & NEPHEW | Healthcare | 1.9% | $4.4m | 140,000 | – | |
| 27 | ZBH ZIMMER BIOMET HOLDINGS INC | Healthcare | 1.8% | $4.3m | 40,000 | – | |
| 28 | RGEN REPLIGEN CORP | Healthcare | 1.6% | $3.7m | 25,000 | – | |
| 29 | MRVI MARAVAI LIFESCIENCES HLDGS-A | Healthcare | 1.5% | $3.5m | 425,000 | – | |
| 30 | HUM HUMANA INC. | Healthcare | 1.4% | $3.2m | 10,000 | – | |
| 31 | TEVA TEVA PHARM ADR | Healthcare | 1.3% | $3.1m | 170,000 | – | |
| 32 | STVN STEVANATO GROUP SPA | 1.2% | $2.8m | 140,000 | – | ||
| 33 | ASND ASCENDIS PHA-ADR | Healthcare | 0.6% | $1.5m | 10,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.